Company intelligence / Profile preview
Tosse
- Ownership
- Private
- Development stage
- Other
Overview
Tosse-Arzneimittel is a traditional German pharmaceutical company with a history dating back to 1920, specializing in respiratory, dermatological, and gastrointestinal health. Based in Hamburg, the company has built a strong reputation for its effective cough and cold treatments, most notably the dihydrocodeine-based antitussive Paracodin. In 2017, Tosse was integrated into the Aristo Pharma Group, a move that expanded its distribution capabilities while maintaining its focus on high-quality medicinal products. The company serves both the prescription and over-the-counter markets, providing essential therapies to patients and healthcare providers across Germany.
- Therapeutic areas
- NeurologyPulmonologyDermatologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Tosse.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tosse.